TY  - JOUR 
AU  - Martín, Miguel
AU  - Pandiella Alonso, Atanasio
AU  - Vargas-Castrillón, Emilio
AU  - Díaz Rodríguez, María Elena
AU  - Iglesias-Hernangómez, Teresa
AU  - Martínez Cano, Concha
AU  - Fernández-Cuesta, Inés
AU  - Winkow, Elena
AU  - Perelló, Maria Francesca
PY  - 2024
SN  - 1040-8428
UR  - http://hdl.handle.net/10366/167788
AB  - [EN]Trastuzumab deruxtecan (T-DXd) is an antibody-drug conjugate (ADC) consisting of a humanised, anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibody covalently linked to a topoisomerase I inhibitor cytotoxic payload (DXd). The...
LA  - eng
KW  - Antibody-drug conjugate; HER2-low metastatic breast cancer; HER2-positive metastatic breast cancer; Trastuzumab deruxtecan
TI  - Trastuzumab deruxtecan in breast cancer
DO  - 10.1016/j.critrevonc.2024.104355
T2  - Critical Reviews in Oncology/Hematology
VL  - 198
M2  - 104355
ER  -